Wednesday, October 15, 2025

Mind Cure Set To Launch Products Into Psychedelic Therapy Adaptogen Supplement Category

Mind Cure Health (CSE: MCUR) has completed the development of its first products. The company has completed the proprietary formulations for what it refers to as “all-natural integrated medicines intended to prepare and support patients of psychedelic therapies.”

The first two products, referred to as Mindful Preparation and Mindful Integration, are intended as pre and post-treatment supplements surrounding the use of psychedelic therapies. The supplements are now expected to be finalized in the current quarter, and made available to therapists and individuals in capsule and powder form in mid-2021.

The products mark Mind Cure’s first foray into products that are designed to be for psychedelic therapy support, a field in which the company intends to become the leader within. The products have been formulated to “encourage an effective healing experience and to balance the brain’s natural chemistry before and after psychedelic treatment.”

“Our mission as innovators within the psychedelic space is to identify areas of care where visionary thinking and leadership can be applied to transform and improve the experience of healing. First, we recognized the opportunity for psychedelic therapy and innovative digital therapeutics with iSTRYM, and now we’re helping to ensure the best, individualized support possible for people throughout their healing journey.”

Kelsey Ramsden, President & CEO of Mind Cure

Mind Cure Health last traded at $0.75 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Silver47 Hits 640 g/t Silver Equivalent Over 6.9 Metres At Red Mountain

Related News

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics...

Tuesday, March 9, 2021, 08:43:32 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE:...

Wednesday, March 16, 2022, 11:58:00 AM

Mind Cure Closes $3.6 Million Oversubscribed Financing

Mind Cure Health (CSE: MCUR) reported midday today that it has closed its non-brokered private...

Thursday, November 19, 2020, 04:28:12 PM

Mind Cure Launches Product Sales Division

Mind Cure Health (CSE: MCUR) continued its constant roll of news this week, announcing this...

Thursday, February 18, 2021, 07:19:26 AM